vs
Side-by-side financial comparison of Agilent Technologies (A) and Brainsway Ltd. (BWAY). Click either name above to swap in a different company.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | — | ||
| Q3 25 | $336.0M | — | ||
| Q2 25 | $215.0M | — | ||
| Q1 25 | $318.0M | — | ||
| Q4 24 | $351.0M | — | ||
| Q3 24 | $282.0M | — | ||
| Q2 24 | $308.0M | — |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 22.4% | — | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 21.1% | — | ||
| Q2 24 | 23.1% | — |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | — | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 12.9% | — | ||
| Q1 25 | 18.9% | — | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 19.6% | — |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | — | ||
| Q3 25 | $1.18 | — | ||
| Q2 25 | $0.75 | — | ||
| Q1 25 | $1.11 | — | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.97 | — | ||
| Q2 24 | $1.05 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
